Does sphenopalatine endoscopic ganglion block have an effect in paroxysmal hemicrania? A case report.
The authors report the case of a 69-year-old woman suffering from paroxysmal hemicrania (PH), intolerant to indomethacin and resistant to multiple therapies, in which sphenopalatine endoscopic ganglion block (SPG) dramatically modified the clinical outcome. SPG blockade could be considered a reasonable alternative in drug-resistant PH cases where indomethacin is contraindicated.
Neurology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy. n.morelli@inwind.it
N
N
Morelli
M
M
Mancuso
G
G
Felisati
P
P
Lozza
A
A
Maccari
G
G
Cafforio
S
S
Gori
L
L
Murri
D
D
Guidetti
D000368:Aged; D000779:Anesthetics, Local / Q000627:therapeutic use*; D001340:Autonomic Nerve Block / Q000379:methods*; D004351:Drug Resistance; D004724:Endoscopy; D005156:Facial Neuralgia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D051302:Paroxysmal Hemicrania / Q000188:drug therapy*; D056739:Pterygopalatine Fossa
D000779:Anesthetics, Local